Cardiology: Online archives of NEJM Journal Watch
- July 2, 2015 |
- Karol E. Watson, MD, PhD, FACC
A phase 2 study helps revive interest in this cholesterol-lowering drug class.
- June 29, 2015 |
- Beat J. Meyer, MD
A new system seems noninferior to cold storage and might hold promise for expanding the donor pool.
- June 26, 2015 |
- Robin Steinhorn, MD
Routine early echocardiographic PDA screening might reduce short-term mortality for extremely preterm infants.
- June 24, 2015 |
- David Green, MD, PhD
Idarucizumab immediately reversed dabigatran-induced increases in clotting variables without causing serious adverse events.
- June 23, 2015 |
Incidental Finding of Coronary Artery Calcification on CT: How Often Is It Reported? How Often Is It Acted On?
- Joel M. Gore, MD
Incidental CAC, an opportunity to implement prevention strategies, is often not reported by radiologists or is ignored by treating physicians.
- June 19, 2015 |
- Ali S. Raja, MD, MBA, MPH, FACEP
Outcomes were either similar or worse for STEMI patients given supplemental oxygen, compared with those who maintained a saturation ≥94% on their own.
- June 19, 2015 |
- Cheryl Lynn Horton, MD
Prehospital therapeutic hypothermia did not shorten the time to target temperature and may have lengthened prehospital times.
- June 17, 2015 |
- David A. Johnson, MD
New findings do not merit changes in PPI prescribing practices for cardiovascular risks alone.
- June 16, 2015 |
Gastrointestinal Bleeding Associated with Dabigatran or Rivaroxaban Is Similar to That Associated with Warfarin
- Paul S. Mueller, MD, MPH, FACP
Nonetheless, clinicians should be cautious when prescribing novel anticoagulants to elders and patients with renal impairment.
- June 11, 2015 |
- Allan S. Brett, MD
Sitagliptin did not improve cardiovascular outcomes in patients with established cardiovascular disease.